Breakthrough scar treatment: Innovo Therapeutics’ INV-001 cuts post-thyroidectomy scars by 24.5%
Innovo Therapeutics Inc. has revealed remarkable results from its Phase 2 clinical trial, demonstrating the efficacy of INV-001 in reducing post-thyroidectomy scars. This innovative treatment achieved a notable 24.5% reduction in scar size with the high (2%) dose compared to a placebo, marking a significant advancement in scar management. The clinical trial, which involved 77 […]